• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patients.腰大肌面积的术后变化作为手术治疗食管癌患者生存的预测指标
J Thorac Dis. 2017 Feb;9(2):355-361. doi: 10.21037/jtd.2017.02.42.
2
Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients.术前总腰大肌面积对手术治疗食管癌患者长期预后的预测价值。
Interact Cardiovasc Thorac Surg. 2017 Jan;24(1):13-19. doi: 10.1093/icvts/ivw274. Epub 2016 Sep 1.
3
Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值对手术治疗的食管鳞状细胞癌患者总生存和无病生存的预后价值
Tumour Biol. 2016 Jun;37(6):7149-54. doi: 10.1007/s13277-015-4596-3. Epub 2015 Dec 12.
4
The prognostic value of total lesion glycolysis via 18F-fluorodeoxyglucose PET-CT in surgically treated esophageal squamous cell carcinoma.18F-氟脱氧葡萄糖PET-CT检测的总病变糖酵解在手术治疗的食管鳞状细胞癌中的预后价值
Ann Nucl Med. 2016 Jan;30(1):81-8. doi: 10.1007/s12149-015-1034-y.
5
Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.临床III期食管鳞状细胞癌患者新辅助化疗与先行手术加或不加化疗的比较。
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12473.
6
Developing sarcopenia predicts long-term mortality after elective endovascular aortic aneurysm repair.发生肌肉减少症可预测择期血管内主动脉瘤修复术后的长期死亡率。
J Vasc Surg. 2020 Apr;71(4):1169-1178.e5. doi: 10.1016/j.jvs.2019.05.060. Epub 2019 Aug 27.
7
The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.老年营养风险指数对食管癌患者食管癌切除术后手术结局的影响。
Esophagus. 2019 Apr;16(2):147-154. doi: 10.1007/s10388-018-0644-6. Epub 2018 Oct 11.
8
Impact of Preoperative Skeletal Muscle Mass and Nutritional Status on Short-and Long-Term Outcomes After Esophagectomy for Esophageal Cancer: A Retrospective Observational Study : Impact of Psoas Muscle Mass and Body Mass on Esophagectomy.术前骨骼肌量和营养状况对食管癌根治术后短期和长期结局的影响:一项回顾性观察研究:腰大肌质量和体重对食管癌根治术的影响。
Ann Surg Oncol. 2019 May;26(5):1301-1310. doi: 10.1245/s10434-019-07188-z. Epub 2019 Feb 6.
9
Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer.内脏脂肪面积(VFA)与腰大肌面积(PMA)之比(V/P比)对手术切除食管癌患者生存的影响
Ann Surg Oncol. 2022 Mar 8. doi: 10.1245/s10434-022-11497-1.
10
[Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].[影响Ⅲ期胸段食管癌患者食管癌切除术后长期生存的因素]
Zhonghua Zhong Liu Za Zhi. 2016 Jul;38(7):530-7. doi: 10.3760/cma.j.issn.0253-3766.2016.07.010.

引用本文的文献

1
Long-term changes in psoas muscle mass after lobectomy and segmentectomy for early-stage lung cancer.早期肺癌肺叶切除术和节段切除术对腰大肌质量的长期影响。
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2540-2549. doi: 10.1002/jcsm.13328. Epub 2023 Sep 23.
2
The Prognostic Value of the GNRI in Patients with Stomach Cancer Undergoing Surgery.GNRI对胃癌手术患者的预后价值
J Pers Med. 2023 Jan 13;13(1):155. doi: 10.3390/jpm13010155.
3
Laparoscopic liver resection is associated with less significant muscle loss than the conventional open approach.腹腔镜肝切除术与传统开腹手术相比,肌肉损失程度较轻。
World J Surg Oncol. 2022 Dec 4;20(1):385. doi: 10.1186/s12957-022-02854-1.
4
Residing in a food desert is associated with an increased risk of readmission following esophagectomy for cancer.居住在食物荒漠地区与食管癌切除术后癌症再入院风险增加有关。
J Thorac Dis. 2022 Jun;14(6):1854-1868. doi: 10.21037/jtd-21-1637.
5
Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization.低腰大肌指数与经动脉化疗栓塞治疗的肝细胞癌患者生存率降低相关。
Ann Med. 2022 Dec;54(1):1562-1569. doi: 10.1080/07853890.2022.2081872.
6
Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era.实体瘤患儿的肌肉减少症:仪器时代。
Cells. 2022 Apr 9;11(8):1278. doi: 10.3390/cells11081278.
7
Prognostic Value of Geriatric Nutritional Risk Index in Esophageal Carcinoma: A Systematic Review and Meta-Analysis.老年营养风险指数在食管癌中的预后价值:一项系统评价与Meta分析
Front Nutr. 2022 Mar 25;9:831283. doi: 10.3389/fnut.2022.831283. eCollection 2022.
8
Severe weight loss after minimally invasive oesophagectomy is associated with poor survival in patients with oesophageal cancer at 5 years.微创食管切除术(minimally invasive oesophagectomy)后严重体重减轻与食管癌(oesophageal cancer)患者 5 年生存率差相关。
BMC Gastroenterol. 2020 Dec 3;20(1):407. doi: 10.1186/s12876-020-01543-1.
9
Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction.术后骨骼肌丢失预示上胃癌和食管胃交界腺癌的预后不良。
World J Surg. 2019 Apr;43(4):1068-1075. doi: 10.1007/s00268-018-4873-6.
10
Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.在肝硬化患者中,腰大肌指数对预测等待名单死亡率高的患者的表现不佳。
J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1053-1062. doi: 10.1002/jcsm.12349. Epub 2018 Sep 29.

本文引用的文献

1
Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients.术前总腰大肌面积对手术治疗食管癌患者长期预后的预测价值。
Interact Cardiovasc Thorac Surg. 2017 Jan;24(1):13-19. doi: 10.1093/icvts/ivw274. Epub 2016 Sep 1.
2
Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer.食管癌切除术后,核心肌肉量减少与患者较差的生存率相关。
Dis Esophagus. 2013 Sep-Oct;26(7):716-22. doi: 10.1111/dote.12020. Epub 2013 Jan 25.
3
Body composition and outcome in patients undergoing resection of colorectal liver metastases.结直肠肝转移瘤切除术后患者的体成分与预后。
Br J Surg. 2012 Apr;99(4):550-7. doi: 10.1002/bjs.7823. Epub 2012 Jan 13.
4
Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer.胸段食管癌术后 1 年生存者体重减轻的预后影响。
Dis Esophagus. 2012 Aug;25(6):527-34. doi: 10.1111/j.1442-2050.2011.01282.x. Epub 2011 Nov 28.
5
Sarcopenia as a prognostic factor among patients with stage III melanoma.肌肉减少症作为 III 期黑色素瘤患者的预后因素。
Ann Surg Oncol. 2011 Dec;18(13):3579-85. doi: 10.1245/s10434-011-1976-9. Epub 2011 Aug 6.
6
Long term nutritional status and quality of life following major upper gastrointestinal surgery - a cross-sectional study.重大上消化道手术后的长期营养状况和生活质量 - 一项横断面研究。
Clin Nutr. 2011 Dec;30(6):774-9. doi: 10.1016/j.clnu.2011.03.003. Epub 2011 Jul 1.
7
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症:欧洲定义和诊断共识:老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
8
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.《美国癌症联合委员会(AJCC)癌症分期手册》第7版:食管和食管胃交界部
Ann Surg Oncol. 2010 Jul;17(7):1721-4. doi: 10.1245/s10434-010-1024-1.
9
Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.超重或肥胖患者的肌肉减少症是胰腺癌的一个不利预后因素。
Clin Cancer Res. 2009 Nov 15;15(22):6973-9. doi: 10.1158/1078-0432.CCR-09-1525. Epub 2009 Nov 3.
10
Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial.富含二十碳五烯酸(EPA)的肠内营养可在食管癌手术后维持瘦体重:一项双盲随机对照试验的结果
Ann Surg. 2009 Mar;249(3):355-63. doi: 10.1097/SLA.0b013e31819a4789.

腰大肌面积的术后变化作为手术治疗食管癌患者生存的预测指标

Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patients.

作者信息

Park Seong Yong, Yoon Joon-Kee, Lee Su Jin, Haam Seokjin, Jung Joonho

机构信息

Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.

Department of Nuclear Medicine & Molecular Imaging, Ajou University School of Medicine, Suwon, Republic of Korea.

出版信息

J Thorac Dis. 2017 Feb;9(2):355-361. doi: 10.21037/jtd.2017.02.42.

DOI:10.21037/jtd.2017.02.42
PMID:28275484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5334111/
Abstract

BACKGROUND

Although a decrease in the psoas muscle area (PMA) has been reported as a risk factor for survival after esophagectomy in esophageal cancer, no previous studies have focused on the change in the PMA after surgery. We investigated the prognostic role of PMA changes in patients with surgically treated esophageal cancer.

METHODS

Fifty-eight patients with esophageal cancer who underwent surgical resection and complete lymph node dissection were reviewed retrospectively. The PMA was measured at the level of the L3 vertebrae on preoperative and one-year postoperative follow-up computed tomography images. The percentage change of the PMA was calculated as follows: delta (%) = (postoperative PMA - preoperative PMA) / (preoperative PMA × 100).

RESULTS

The study patients included 54 (93.1%) males and 4 females (mean age, 60.59±9.16 years), of whom 17 (29.3%) were pathological Stage I, 18 (31.0%) were Stage II, and 23 (39.7%) were Stage III. The mean change of the PMA was -10.17% and the postoperative PMA was decreased significantly compared with the preoperative PMA (P<0.001). The PMA was increased in 13 (22.4%) patients, whereas it was decreased in 45 (77.6%). Multivariate analysis revealed that the change of the PMA (hazard ratio, HR =0.688; P=0.001) and the pathologic stage (Stage III . Stage I, HR =3.388; P=0.016) were risk factors for overall survival (OS). The 3-year OS in patients with a PMA decrease of more than 10%, and those with a PMA decrease of less than 10% or an increase, were 18.9% and 59.5%, respectively (P=0.049).

CONCLUSIONS

The decrease in the PMA had a negative prognostic effect on OS in patients with surgically treated esophageal cancer.

摘要

背景

尽管已有报道称腰大肌面积(PMA)减小是食管癌患者食管切除术后生存的危险因素,但此前尚无研究关注术后PMA的变化。我们调查了PMA变化在接受手术治疗的食管癌患者中的预后作用。

方法

回顾性分析了58例行手术切除及完整淋巴结清扫的食管癌患者。在术前及术后1年的随访计算机断层扫描图像上,于L3椎体水平测量PMA。PMA的百分比变化计算如下:δ(%)=(术后PMA - 术前PMA)/(术前PMA×100)。

结果

研究患者包括54名男性(93.1%)和4名女性(平均年龄60.59±9.16岁),其中17例(29.3%)为病理I期,18例(31.0%)为II期,23例(39.7%)为III期。PMA的平均变化为-10.17%,术后PMA较术前显著降低(P<0.001)。13例(22.4%)患者PMA增加,45例(77.6%)患者PMA降低。多因素分析显示,PMA变化(风险比,HR =0.688;P=0.001)和病理分期(III期. I期,HR =3.388;P=0.016)是总生存(OS)的危险因素。PMA降低超过10%的患者与PMA降低不足10%或增加的患者相比,3年总生存率分别为18.9%和59.5%(P=0.049)。

结论

PMA降低对接受手术治疗的食管癌患者的OS有负面预后影响。